Monday, April 20, 2020

Baxter Safety Data Coordinator Quality, Pharmacovigilance or Regulatory department


Baxter Safety Data Coordinator Quality, Pharmacovigilance or  Regulatory department

Essential Duties and Responsibilities:
This section contains a list of five to eight primary responsibilities of this role that account for 5% or more of the work. The incumbent will perform other duties assigned.
Responsibilities include, but are not limited to the following:
Perform reconciliation activities with organizations within Baxter.
Perform reconciliation with external business partners
Provide feedback both internally and externally regarding discrepancies found in ICSRs.
Analyze requests for potential data corrections and ensure that needed corrections are completed.
Escalate issues with reconciliation compliance.
Identify opportunities for process improvements for reconciliation activities.
Qualifications:
To perform this job successfully, an individual must be able to perform each essential duty satisfactorily. List knowledge, skills, and/or abilities required. Reasonable accommodations may be made to enable individuals with disabilities to perform essential functions.
Proficiency in working with Microsoft Office tools-Outlook, Excel, Word.
Proficiency in a Global Safety Database (e.g., ARISg, Argus)
Excellent attention to detail in documentation.
Knowledge of medical, clinical or health sciences.
Excellent analytical & problem solving skills
Excellent oral and written communication
Collaborative interpersonal skills to foster a team environment
Ability to work independently under strict deadlines and changing priorities
Able to multitask and prioritize changing workload on a daily basis
Education and/or Experience:
Include the education and experience that is necessary to perform the job satisfactorily.
Experience in pharmaceutical industry- Quality, Pharmacovigilance or  Regulatory department
In health sciences, preferably pharmacist or nurse.


TO APPLY CLICK HERE

FOR MORE JOB UPDATES



JOIN IN GROUP FOR DAILY UPDATES


No comments:

Post a Comment